{"version":"1.0","provider_name":"France Angels","provider_url":"https:\/\/www.franceangels.org\/en\/","author_name":"sylvain Godard","author_url":"https:\/\/www.franceangels.org\/en\/article\/author\/sylvainfranceangels-org\/","title":"Femmes Business Angels accompagne Hepha\u00efstos - France Angels","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"TF8zKko6y0\"><a href=\"https:\/\/www.franceangels.org\/en\/article\/femmes-business-angels-accompagne-hephaistos\/\">Femmes Business Angels accompagne Hepha\u00efstos<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.franceangels.org\/en\/article\/femmes-business-angels-accompagne-hephaistos\/embed\/#?secret=TF8zKko6y0\" width=\"600\" height=\"338\" title=\"&#8220;Femmes Business Angels accompagne Hepha\u00efstos&#8221; &#8212; France Angels\" data-secret=\"TF8zKko6y0\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/*! This file is auto-generated *\/\n!function(c,d){\"use strict\";var e=!1,o=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(\/[^a-zA-Z0-9]\/.test(t.secret));else{for(var r,s,a,i=d.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),n=d.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),o=new RegExp(\"^https?:$\",\"i\"),l=0;l<n.length;l++)n[l].style.display=\"none\";for(l=0;l<i.length;l++)if(r=i[l],e.source!==r.contentWindow);else{if(r.removeAttribute(\"style\"),\"height\"===t.message){if(1e3<(s=parseInt(t.value,10)))s=1e3;else if(~~s<200)s=200;r.height=s}if(\"link\"===t.message)if(s=d.createElement(\"a\"),a=d.createElement(\"a\"),s.href=r.getAttribute(\"src\"),a.href=t.value,!o.test(a.protocol));else if(a.host===s.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener(\"message\",c.wp.receiveEmbedMessage,!1),d.addEventListener(\"DOMContentLoaded\",t,!1),c.addEventListener(\"load\",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf(\"MSIE 10\"),a=!!navigator.userAgent.match(\/Trident.*rv:11\\.\/),i=d.querySelectorAll(\"iframe.wp-embedded-content\"),n=0;n<i.length;n++){if(!(r=(t=i[n]).getAttribute(\"data-secret\")))r=Math.random().toString(36).substr(2,10),t.src+=\"#?secret=\"+r,t.setAttribute(\"data-secret\",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute(\"security\"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:\"ready\",secret:r},\"*\")}}}}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2026\/05\/Visuels-articles-7.png","thumbnail_width":1633,"thumbnail_height":805,"description":"Femmes Business Angels a de nouveau particip\u00e9 \u00e0 la nouvelle lev\u00e9e de fonds d\u2019Hepha\u00efstos, une startup biotech d\u00e9veloppant une immunoth\u00e9rapie anti-cancer intraveineuse ciblant les tumeurs froides. Fond\u00e9e par Fr\u00e9d\u00e9ric CAROFF, la soci\u00e9t\u00e9 d\u00e9veloppe un agoniste TLR4 d\u00e9toxifi\u00e9 actuellement en phase pr\u00e9clinique avanc\u00e9e, avec l\u2019ambition d\u2019ouvrir de nouvelles perspectives th\u00e9rapeutiques sur des cancers aujourd\u2019hui difficiles \u00e0&hellip;"}